Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	546.05	453	311.66	243.78	234.31	228.63
Short-Term Investments	19.22	14.19	41.8	79.33	-	-
Cash & Short-Term Investments	565.27	467.19	353.46	323.12	234.31	228.63
Cash Growth	62.94%	32.17%	9.39%	37.90%	2.48%	834.83%
Receivables	92.98	83.03	74.14	54.74	34.84	22.18
Inventory	6.1	7.2	5.36	4.3	4.43	3.82
Prepaid Expenses	18.36	13.71	12.57	9.35	7.64	6.96
Other Current Assets	8.64	8.12	5.54	8.79	3.22	1.3
Total Current Assets	691.35	579.25	451.07	400.29	284.44	262.89
Property, Plant & Equipment	2.65	3.38	2.72	2.89	4.12	0.94
Long-Term Investments	107.01	108.87	72.17	22.57	-	-
Other Intangible Assets	101.34	113.26	137.11	160.95	143.92	162.34
Long-Term Deferred Tax Assets	201.19	190.4	144.16	85.94	-	-
Other Long-Term Assets	4.46	4.03	4.22	1.24	0.97	0.9
Total Assets	1,108	999.2	811.45	673.87	433.44	427.07
Accounts Payable	28.3	13.74	17.73	3.79	1	2.56
Accrued Expenses	130.03	139.42	123.24	71.47	49.41	31.67
Current Portion of Long-Term Debt	18.75	16.25	15	2	2	-
Current Portion of Leases	0.85	1.32	1.44	1.61	1.36	-
Other Current Liabilities	2.21	4.35	6.37	0.01	-	100.31
Total Current Liabilities	180.14	175.08	163.78	78.88	53.78	134.54
Long-Term Debt	153.35	163.02	178.57	189.65	189.98	194.25
Long-Term Leases	0.43	0.82	1.08	0.98	2.4	-
Other Long-Term Liabilities	1.02	1.13	1.03	1.53	0.78	1.11
Total Liabilities	334.93	340.05	344.46	271.03	246.94	329.89
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	685.29	656.87	610.27	675.12	640.1	585.37
Retained Earnings	87.55	2.22	-143.28	-272.13	-453.6	-488.2
Comprehensive Income & Other	0.24	0.07	0	-0.15	-	-
Total Common Equity	773.08	659.16	466.99	402.84	186.51	97.18
Shareholders' Equity	773.08	659.16	466.99	402.84	186.51	97.18
Total Liabilities & Equity	1,108	999.2	811.45	673.87	433.44	427.07
Total Debt	173.37	181.41	196.09	194.24	195.74	194.25
Net Cash (Debt)	391.9	285.78	157.38	128.88	38.57	34.38
Net Cash Growth	148.28%	81.59%	22.11%	234.19%	12.17%	-
Net Cash Per Share	6.72	4.94	2.61	2.11	0.65	1.33
Filing Date Shares Outstanding	57.53	57.35	56.77	59.62	58.87	56.89
Total Common Shares Outstanding	57.54	57.14	56.77	59.62	58.83	56.89
Working Capital	511.22	404.17	287.29	321.4	230.66	128.35
Book Value Per Share	13.44	11.53	8.23	6.76	3.17	1.71
Tangible Book Value	671.74	545.89	329.88	241.89	42.59	-65.16
Tangible Book Value Per Share	11.67	9.55	5.81	4.06	0.72	-1.15

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q